5α-Reductase converts:
TESTOSTERONE ➔ DIHYDROTESTOSTERONE (DHT) (normally in males)
Mainly in peripheral tissue, but also in testes; DHT is significantly more potent than TESTOSTERONE, and thought to be involved in prostate enlargement, prostate cancer and PCOS.
There are two 5AR forms (isoenzymes)
- 5-alpha reductase 1 (SRD5A1) - used to create neurosteroids
- 5-alpha reductase 2 (SRD5A2) - converts TESTOSTERONE ➔ DHT
5AR Inhibited by:
• PROGESTERONE
• Drugs (E.g. Finasteride , Dutasteride) - used against prostate cancer and male pattern baldness
• Saw Palmetto (Serenoa repens)
• Willow herb - contains oenothein B, with 5AR inhibitor activity
• Astaxanthin - this carotenoid has demonstrated some 5AR inhibitor activity
• Black cohosh (Cimicifuga racemosa)
Maturitas. 2006.Department of Clinical and Experimental Endocrinology, University of Goettingen, Robert-Koch-Strasse, Gottingen, Germany
- 5AR Inhibitor (5ARI) drugs (E.g. Finasteride , Dutasteride) have been associated with adverse outcomes, which side-effects may also be experienced with any natural 5AR inhibitor:
• Adverse sexual outcomes - such as lack of libido, erectile dysfunction (ED), and ejaculatory dysfunction (EjD). Since NO (nitric oxide) is required to maintain an erection, a suggested theory is that lack of DHT inhibits nitric oxide synthase (NOS) activity.
• Anxiety / Depression - common side effects of 5ARI s believed to be caused, in part, by the prevention of the endogenous production of the neurosteroid allopregnanolone from PROGESTERONE
• Cancer
• Finasteride - inhibits the function of only type 2 form of 5AR (SRD5A2); however, it was found in a study of 18,000 healthy men, that although the finasteride group had a lower incidence of cancer (18.4% vs. 24.4%) there were more cases of aggressive cancer with finasteride than with placebo group (37% vs. 22.2%, P<0.001).
• Dutasteride - inhibits both forms of 5AR (SRD5A2 and SRD5A2);